Dupilumab facial dermatitis in atopic dermatitis patients ameliorated by topical crisaborole: An open-label case series study

被引：0

作者：

Lin, Han-Wen ^{[1
]}

Chung, Wen-Hung ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
,11
,12
,13
]}

Chen, Chun-Bing ^{[1
,2
,3
,4
,5
,6
,7
,8
,9
,10
]}

机构：

[1] Chang Gung Mem Hosp, Drug Hypersensit Clin & Res Ctr, Dept Dermatol, 5 Fuxing St, Taipei 33305, Taiwan

[2] Chang Gung Mem Hosp, Dept Med Res, Canc Vaccine & Immune Cell Therapy Core Lab, Linkou, Taiwan

[3] Chang Gung Univ, Chang Gung Mem Hosp, Chang Gung Immunol Consortium, Linkou, Taiwan

[4] Xiamen Chang Gung Hosp, Dept Dermatol, Xiamen 361028, Peoples R China

[5] Xiamen Chang Gung Hosp, Xiamen Chang Gung Allergol Consortium, Xiamen, Peoples R China

[6] Natl Tsing Hua Univ, Sch Med, Hsinchu, Taiwan

[7] Chang Gung Univ, Coll Med, Taoyuan, Taiwan

[8] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan

[9] Chang Gung Mem Hosp, Immune Oncol Ctr Excellence, Linkou, Taiwan

[10] Chang Gung Mem Hosp, Whole Genome Res Core Lab Human Dis, Keelung, Taiwan

[11] Tsinghua Univ, Beijing Tsinghua Chang Gung Hosp, Sch Clin Med, Dept Dermatol, Beijing, Peoples R China

[12] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Dermatol, Shanghai, Peoples R China

[13] Chang Gung Mem Hosp, Genom Med Core Lab, Linkou, Taiwan

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年 / 39卷 / 02期

关键词：

D O I：

10.1111/jdv.20281

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页码：e181 / e183

页数：3

共 50 条

[1] Open-label trial of dupilumab for adolescents with atopic dermatitis
Ingram, John
BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (01) : IX - IX
[2] Facial Redness in Atopic Dermatitis Patients Treated With Dupilumab: A Case Series
Seok, Seung Hui
An, Ji Hae
Shin, Jung U.
Lee, Hee Jung
Kim, Dong Hyun
Yoon, Moon Soo
Kim, Hyun Jung
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2020, 12 (06) : 1063 - 1065
[3] Facial erythema during dupilumab treatment for atopic dermatitis successfully remedied with topical crisaborole ointment: A case report
Tsai, Ya-Chu
Tsai, Tsen-Fang
DERMATOLOGIC THERAPY, 2022, 35 (11)
[4] An Open-Label Prospective Observational Study of Tralokinumab in Atopic Dermatitis Patients with Inadequate Response to Dupilumab
Polaskey, Meredith Tyree
Fakhraie, Sheiva
Daftary, Karishma
Chovatiya, Raj
DERMATITIS, 2024,
[5] Tralokinumab in the treatment of resistant atopic dermatitis: An open-label, retrospective case series study
Pezzolo, Elena
Naldi, Luigi
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (05) : E644 - E645
[6] Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open-Label Phase 2a Study
Tom, Wynnis L.
Van Syoc, Merrie
Chanda, Sanjay
Zane, Lee T.
PEDIATRIC DERMATOLOGY, 2016, 33 (02) : 150 - 159
[7] Measuring and improving adherence to topical crisaborole in patients with atopic dermatitis
Snyder, Stephanie N.
Bashyam, Arjun M.
Strowd, Lindsay C.
Feldman, Steven
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB105 - AB105
[8] Atopic dermatitis, dupilumab and cancers: a case series
Siliquini, N.
Giura, M. T.
Viola, R.
Ribero, S.
Panzone, M.
Dapavo, P.
Fierro, M. T.
Ortoncelli, M.
Quaglino, P.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (10) : E651 - E652
[9] Transient hypogammaglobulinemia and severe atopic dermatitis: Open-label treatment with immunoglobulin in a case series
Breslin, Moira E.
Lin, Joanna H.
Roberts, Robert
Lim, Kellie J.
Stiehm, E. Richard
ALLERGY & RHINOLOGY, 2016, 7 (02) : E69 - E73
[10] SAFETY AND EFFICACY OF OPEN-LABEL DUPILUMAB IN ADULT PATIENTS WITH ATOPIC DERMATITIS: AN INTERIM ANALYSIS AT WEEK 76
Gebauer, Kurt
Rubel, Diana
Deleuran, Mette
Thaci, Diamant
Boguniewicz, Mark
Bissonnette, Robert
Chen, Zhen
Gadkari, Abhijit
Eckert, Laurent
Rossi, Ana B.
Ardeleanu, Marius
INTERNAL MEDICINE JOURNAL, 2019, 49 : 19 - 19

← 1 2 3 4 5 →